An interventional study of Cognitive behavioral therapy for insomnia (CBT-I) and Sleep education therapy (SET) in Osteoarthritis, Knee, Osteoarthritis, Hip and Insomnia, sponsored by Uppsala University. Recruiting at 1 site in Sweden. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-05-06.
Sponsored by Uppsala University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Osteoarthritis, Knee with a site in Sweden — 12 open to participants now, 19 under way, none of them phase 3. Osteoarthritis, Knee · Sweden.
Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, this one is the 27th largest by planned enrollment of the 38 interventional ones that give a count, is one of 4 that started in 2025, is one of 23 with no phase, reaches primary completion later than 15 of the 18 other live ones, and was the 41st registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →12 of the 54 studies in Osteoarthritis, Knee with a site in Sweden are open now. Recruiting first, the newest first:
Vastra Gotaland Region · Sites in Sweden
Ages 30+
Vastra Gotaland Region · Sites in Sweden
Ages 18+
Region Skane · Sites in Sweden
Ages 25+
Danderyd Hospital · Sites in Sweden
Ages 18+
Linkoeping University · Sites in Sweden
Ages 40–85
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 6 · Phase 3 7
First in 2005; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 175 across the 38 interventional studies, 246 across the 16 observational. Of the 30 that completed or were terminated, 8 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 54 have an industry lead sponsor. The 10 most frequent:
Uppsala University is the lead sponsor of 390 studies on the registry; 86 are open to participants now.
Uppsala University has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
5 of the studies in Osteoarthritis, Knee with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05584410Vastra Gotaland RegionDigitalization of Osteoarthritis Care | 2026-12-31 |
| NCT07212920Vastra Gotaland RegionValidity and Reliability of Video-Based Functional Physiotherapy Assessment of Subacute Knee Injuries | 2026-12-31 |
| NCT06459700Lund UniversityEffect of Probiotic Supplements on Osteoarthritis Outcomes | 2027-04-30 |
| NCT07875647Mälardalen UniversityPerson-Centred Digital Rehabilitation for Knee Osteoarthritis | 2027-09 |
| NCT07383740Vastra Gotaland RegionTest-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis | 2027-09-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
PROSAP-A is a perioperative randomized, controlled trial with a 12-month follow-up period after total knee arthroplasty (TKA) or total hip arthroplasty (THA), aiming to investigate both acute and long-term postoperative effects of preoperative sleep-promotion. Participants with clinically significant insomnia symptoms will be randomized to a brief, hybrid version of cognitive behavioral therapy for insomnia (CBT-I) or sleep education therapy, administered over a 4-week period, prior to surgery. The primary objective is to evaluate effects of preoperative sleep-promotion on acute postoperative pain control. Secondary objectives include evaluation of postoperative sleep, recovery, mental health, cognitive function and alterations in blood biomarkers.
Although preoperative sleep disturbance is associated with poorer acute postoperative pain control, as well as development of chronic postsurgical pain, only very limited attempts have been made to target preoperative sleep to achieve improved postoperative outcomes. This study addresses two chronic pain populations, TKA and THA patients, that suffer severely due to both sleep disturbance and painful symptoms. Patients who meet eligibility criteria, including insomnia severity index score >10 and confirmed DSM-V criteria for persistent insomnia disorder, will be randomized to a brief, hybrid version of CBT-I or sleep education therapy over a 4-week period, before surgery. The CBT-I will focus on the two components which have shown the highest efficacy for sleep improvement, sleep restriction therapy and stimulus control. The CBT-I treatment will be administered in self-guided digital format with addition of telehealth video-consultations with a psychologist one time per week. The sleep education therapy will also be provided in a hybrid format, including digital sessions and video-consultations with a research nurse. There will also be a booster session 1-2 weeks postoperative for both interventions. Participants will be carefully evaluated during on-site visits two times preoperative, pre- and post-intervention, and one time 6 months postoperative. During on-site visits, participants will complete multiple questionnaires (covering pain, pain catastrophizing, mental health, physical function, activity etc), undergo digital cognitive testing, quantitative sensory testing (QST, to determine pain detection thresholds to different stimuli, assess temporal summation, pain inhibitory capacity), provide blood samples, and initiate actigraphy (objective assessment of sleep continuity measures). In addition to the on-site visits, participants will complete questionnaires remotely 3 and 12 months after surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The CBT-I treatment will be administered in self-guided digital format over 4 weeks with addition of telehealth video-consultations with a psychologist one time per week. The CBT-I will focus on sleep restriction therapy and stimulus control, which have shown the highest efficacy for sleep improvement among components typically incorporated. A booster session will be provided 1-2 weeks postoperative.
Behavioral: Cognitive behavioral therapy for insomnia (CBT-I)
The sleep education therapy will be administered in self-guided digital format over 4 weeks with addition of telehealth video-consultations with a research nurse one time per week. The SET will focus on sleep physiology, different sleep disturbances and sleep hygiene measures. A booster session will be provided 1-2 weeks postoperative.
Behavioral: Sleep education therapy (SET)
Hybrid CBT-I (self-guided digital format focusing on sleep restriction therapy and stimulus control + telehealth video-consultations with psychologist)
Self-guided digital sleep education (sleep hygiene, sleep physiology, sleep disturbances etc) + telehealth video-consultations with research nurse
Acute postoperative pain intensity
Average pain intensity (NRS 0 - 10) over the past 24 h rated each morning, averaged over 7 days
Time frame: First 7 postoperative days
Pre- and acute postoperative change in sleep measures from baseline
insomnia severity index, Pittsburgh sleep quality index, actigraphic sleep continuity measures (sleep onset latency, total sleep time, wakefulness after sleep onset, sleep efficiency)
Time frame: Up to 2 weeks postoperative
Acute postoperative opioid consumption
Oral morphine mg equivalents (OMEQs)
Time frame: Postoperative day (POD) 1 and POD1-7
Recovery in the acute postoperative phase
Quality of recovery (QoR) 15 score
Time frame: First 7 postoperative days
Long-term postoperative sleep quality
insomnia severity index
Time frame: Up to 12 months postoperative
Postoperative objective sleep continuity
actigraphic sleep efficiency \[SE\]
Time frame: Up to 6 months postoperative
Pain intensity 6 months postoperative
Average pain intensity (NRS 0 - 10) over the past 24 h rated each morning, averaged over 7 days
Time frame: 6 months postoperative
Change in pain measures from baseline
BPI pain severity and pain interference score, QoR-15 pain score, WOMAC OA pain score
Time frame: Up to 12 months postoperative
Changes in quantitative sensory testing (QST) measures of pain
Pressure pain threshold, temporal summation, conditioned pain modulation, cold pressor test
Time frame: Up to 6 months postoperative
Change in cognitive function
Digital cognitive testing (Mindmore platform) incl. memory, attention and processing speed, executive functions
Time frame: Up to 6 months postoperative
Change in anxiety from baseline
Generalized anxiety disorder 7 (GAD-7) score
Time frame: Up to 6 months postoperative
Change in depression from baseline
Patient health questionnaire 9 (PHQ-9) score
Time frame: Up to 6 months postoperative
Change in quality of life
EuroQol 5 dimension 5 level (EQ-5D-5L), RAND-36
Time frame: Up to 6 months postoperative
Change in health-related function
EQ-5D-5L, RAND-36
Time frame: Up to 6 months postoperative
Change in osteoarthritis-related symptoms
WOMAC OA
Time frame: Up to 12 months postoperative
Change in physical activity
International physical activity questionnaire short form (IPAQ-sf)
Time frame: Up to 6 months postoperative
Change in pain catastrophizing
Pain catastrophizing scale (PCS)
Time frame: Up to 6 months postoperative
Change in kinesiophobia
Tampa scale of kinesiophobia (TSK)
Time frame: Up to 6 months postoperative
Change in subjective pain sensitivity
Pain sensitivity questionnaire (PSQ)
Time frame: Up to 6 months postoperative
Fibromyalgia severity score
Sum of widespread pain index + symptom severity scale (ACR 2016)
Time frame: Up to 6 months postoperative
Pain-related acceptance
Chronic pain acceptance questionnaire (CPAQ-8)
Time frame: Up to 6 months postoperative
Changes in blood biomarkers
Inflammatory mediators, monoamine metabolites, coagulation system etc
Time frame: Up to 6 months postoperative
Plan to share: No
Started Sep 2025 (actual). Primary completion is estimated for Dec 2029, 51 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 51 months is above that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.